A1a.1. Kostakoglu L, Uysal U, Ozyar E, Elahi N, Hayran M, Uzal D, Demirkazik FB, Kars A, Ugur O, Atahan L, Bekdik CF. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. J Nucl Med. 1996; 37: 1956-62.

A1a.2. Arslan S, Saatci U, Ozen S, Bakkaloglu A, Besbas N, Tinaztepe K, Hayran M. Membranoproliferative glomerulonephritis in childhood: factors affecting prognosis. Int Urol Nephrol. 1997; 29: 711-6.

A1a.3. Kars A, Celik I, Kansu E, Tekuzman G, Ozisik Y, Guler N, Barista I, Gullu I, Yalcin S, Altundag K, Zengin N, Turker A, Hayran M, Baltali E, Firat D. Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma. Eur J Haematol. 1997; 59: 100-4.

A1a.4. Agalar F, Sayek I, Agalar C, Cakmakci M, Hayran M, Kavuklu B. Factors that may increase morbidity in a model of intra-abdominal contamination caused by gallstones lost in the peritoneal cavity. Eur J Surg. 1997; 163: 909-14.

A1a.5. Kostakoglu L, Uysal U, Ozyar E, Hayran M, Uzal D, Demirkazik FB, Kars A, Atahan L, Bekdik CF. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. J Nucl Med. 1997; 38: 1009-14.

A1a.6. Kostakoglu L, Elahi N, Kiratli P, Ruacan S, Sayek I, Baltali E, Sungur A, Hayran M, Bekdik CF. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. J Nucl Med. 1997; 38: 1003-8.

A1a.7. Kostakoglu L, Uysal U, Ozyar E, Demirkazik FB, Hayran M, Atahan L, Bekdik CF. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma. Eur J Nucl Med. 1997; 24: 621-8.

A1a.8. Alatas C, Aksoy E, Akarsu C, Yakin K, Aksoy S, Hayran M. Evaluation of intrauterine abnormalities in infertile patients by sonohysterography. Hum Reprod. 1997; 12: 487-90.

A1a.9. Kostakoglu L, Kiratli P, Ruacan S, Hayran M, Emri S, Ergun EL, Bekdik CF. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med. 1998; 39: 228-34.

A1a.10. Uzal D, Ozyar E, Hayran M, Zorlu F, Atahan L, Yetkin S. Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia. Radiother Oncol. 1998; 48: 29-32.

A1a.11. Benekli M, Gullu IH, Tekuzman G, Savas MC, Hayran M, Hascelik G, Firat D. Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer. Br J Cancer. 1998; 78: 267-71.

A1a.12. Kostakoglu L, Guc D, Canpinar H, Kars A, Alper E, Kiratli P, Hayran M, Gunduz U, Kansu E. P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy. J Nucl Med. 1998; 39: 1191-7.

A1a.13. Zengin N, Kars A, Sungur A, Zengin NI, Hayran M, Tekuzman G, Kansu E, Ruacan S, Firat D. The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemma. Am J Hematol. 1999; 62: 208-11.

A1a.14. Garipagaoglu M, Yalvac S, Kose MF, Tulunay G, Kayikcioglu F, Cakmak A, Haberal A, Boran N, Adli M, Hayran M. Treatment results and prognostic factors in inoperable carcinoma of the cervix treated with external plus high dose brachytherapy. Cancer Lett. 1999; 136: 17-26.

A1a.15. Cengiz M, Ozyar E, Ozturk D, Akyol F, Atahan IL, Hayran M. Sucralfate in the prevention of radiation-induced oral mucositis. J Clin Gastroenterol. 1999; 28: 40-3.

A1a.16. Gulaldi NC, Kostakoglu L, Uzal D, Hayran M, Elahi N, Uysal U, Aktas A, Atahan L, Bekdik C. Impact of radiotherapy on normal brain tissue: semi-automated quantification of decrease in perfusion. Ann Nucl Med. 2000; 14: 17-23.

A1a.17. Ustun C, Beksac M, Dalva K, Koc H, Konuk N, Ilhan O, Ozcan M, Topcuoglu P, Sertkaya D, Hayran M. In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia. Med Oncol. 2002; 19: 59-67.

A1a.18. Schoen RE, Weissfeld JL, Trauth JM, Ling BS, Hayran M. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer. Am J Gastroenterol. 2002; 97: 446-51.

A1a.19. Kaptanoglu E, Palaoglu S, Surucu HS, Hayran M, Beskonakli E. Ultrastructural scoring of graded acute spinal cord injury in the rat. J Neurosurg. 2002; 97: 49-56.

A1a.20. Bayramoglu A, Aydingoz U, Hayran M, Ozturk H, Cumhur M. Comparison of qualitative and quantitative analyses of age-related changes in clivus bone marrow on MR imaging. Clin Anat. 2003; 16: 304-8.

A1a.21. Trauth JM, Ling BS, Weissfeld JL, Schoen RE, Hayran M. Using the transtheoretical model to stage screening behavior for colorectal cancer. Health Educ Behav. 2003; 30: 322-36.

A1a.22. Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz A, Dalmaz G, Uzal C, Hicsonmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioglu U, Demiral AN, Hayran M. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys. 2005; 63: 1347-53.

A1a.23. Altun B, Yilmaz R, Kahraman S, Genctoy G, Arici M, Onalan O, Oto A, Hayran M, Bakkaloglu M, Yasavul U, Turgan C. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients. Transpl Int. 2005; 18: 681-9.

A1a.24. Uner AH, Saglam A, Han U, Hayran M, Sungur A, Ruacan S. PTEN and p27 expression in mature T-cell and NK-cell neoplasms. Leuk Lymphoma. 2005; 46: 1463-70.

A1a.25. Aliefendioglu D, Gursoy T, Hayran KM, Aslan AT. Can cerebrospinal fluid uric acid levels differentiate intraventricular hemorrhage from traumatic tap? Biol Neonate. 2006; 90: 268-72.

A1a.26. Metan G, Hayran M, Hascelik G, Uzun O. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis. 2006; 38: 527-31.

A1a.27. Keles I, Aydin G, Basar MM, Hayran M, Atalar E, Orkun S, Batislam E. Endogenous sex steroids and bone mineral density in healthy men. Joint Bone Spine. 2006; 73: 80-5.

A1a.28. Yalcin B, Tamer E, Toy GG, Oztas P, Hayran M, Alli N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006; 45: 672-6.

A1a.29. Hayran M, Koca E, Haznedaroglu IC, Unsal I, Durgun B, Guvenc F, Ozturk B, Ratip S, Ozcebe OI. Predicting chronic leukaemias from assessment of complete peripheral blood counts. J Int Med Res. 2006; 34: 640-7.

A1a.30. Kisacik B, Kalyoncu U, Erol MF, Karadag O, Yildiz M, Akdogan A, Kaptanoglu B, Hayran M, Ureten K, Ertenli I, Kiraz S, Calguneri M. Accurate diagnosis of acute abdomen in FMF and acute appendicitis patients: how can we use procalcitonin? Clin Rheumatol. 2007; 26: 2059-62.

A1a.31. Aksoy DY, Tanriover MD, Uzun O, Zarakolu P, Ercis S, Erguven S, Oto A, Kerimoglu U, Hayran M, Abbasoglu O. Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis. Ann Oncol. 2007; 18: 183-9.

A1a.32. Tufan A, Babaoglu MO, Akdogan A, Yasar U, Calguneri M, Kalyoncu U, Karadag O, Hayran M, Ertenli AI, Bozkurt A, Kiraz S. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol. 2007; 34: 1540-4.

A1a.33. Erbil KM, Uz A, Hayran M, Mas N, Senan S, Tuncel M. The relationship of the parotid duct to the buccal and zygomatic branches of the facial nerve; an anatomical study with parameters of clinical interest. Folia Morphol (Warsz). 2007; 66: 109-14.

A1a.34 Yavas O, Hayran M, Ozisik Y. Factors affecting survival in breast cancer patients following bone metastasis. Tumori. 2007; 93: 580-6.

A1a.35. Kerimoglu U, Hayran M, Ergen FB, Kirkpantur A, Turgan C. Sonographic evaluation of entheseal sites of the lower extremity in patients undergoing hemodialysis. J Clin Ultrasound. 2007; 35: 417-23.

A1a.36 Guler G, Iliopoulos D, Guler N, Himmetoglu C, Hayran M, Huebner K. Wwox and Ap2gamma expression levels predict tamoxifen response. Clin Cancer Res. 2007; 13: 6115-21.

A1a.37. Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Acta Oncol. 2008; 47: 232-8.

A1a.38. Buyukdamgaci-Alogan G, Elele T, Hayran M, Erman M, Kilickap S. A decision-analytic model for early stage breast cancer: lumpectomy vs mastectomy. Neoplasma. 2008; 55: 222-8.

A1a.39. Oksuzoglu B, Abali H, Hayran M, Yildirim N, Budakoglu B, Zengin N. Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes. Chemotherapy. 2008; 54: 352-6.

A1a.40. Kepez A, Akdogan A, Sade LE, Deniz A, Kalyoncu U, Karadag O, Hayran M, Aytemir K, Ertenli I, Kiraz S, Calguneri M, Kabakci G, Tokgozoglu L. Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imaging. Echocardiography. 2008; 25: 191-7.

A1a. 41. Ergen FB, Akata D, Sarikaya B, Kerimoglu U, Hayran M, Akhan O, Hussain HK. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings. J Comput Assist Tomogr. 2008; 32: 54-60.

A1a.42. Ozsoy MH, Bayramoglu A, Demiryurek D, Tuccar E, Hayran M, Dincel VE, Atay OA, Cavusoglu AT. Rotator interval dimensions in different shoulder arthroscopy positions: a cadaveric study. J Shoulder Elbow Surg. 2008; 17: 624-30.

A1a.43. Erkekol FO, Celik GE, Hayran M, Dursun BA, Goksel OK, Misirligil MS, Demirel YS. The prevalence of latex allergy in sixth-year medical students: assessment of knowledge, risk, and attitudes about future specialty direction. Ann Allergy Asthma Immunol. 2008; 100: 576-82.

A1a.44. Aksoy S, Kilickap S, Hayran M, Harputluoglu H, Koca E, Dede DS, Erman M, Turker A. Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. Int J Lab Hematol. 2008; 30: 214-9.

A1a.45. Akel I, Pekmezci M, Hayran M, Genc Y, Kocak O, Derman O, Erdogan I, Yazici M. Evaluation of shoulder balance in the normal adolescent population and its correlation with radiological parameters. Eur Spine J. 2008; 17: 348-54.

A1a.46. Harputluoglu H, Dizdar O, Aksoy S, Kilickap S, Dede DS, Ozisik Y, Guler N, Barista I, Gullu I, Hayran M, Selek U, Cengiz M, Zorlu F, Tekuzman G, Altundag K. Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc. 2008; 100: 521-6.

A1a.47. Atahan IL, Ozyigit G, Yildiz F, Gurkaynak M, Selek U, Sari S, Hayran M. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy. Breast J. 2008; 14: 245-9.

A1a.48. Gursoy T, Yurdakok M, Hayran M, Korkmaz A, Yigit S, Tekinalp G. Bone speed of sound curves of twin and singleton neonates. J Pediatr Endocrinol Metab. 2008; 21: 1065-71.

A1a.49. Ergen FB, Akata D, Hayran M, Harmanci O, Arslan S, Basaran C, Hussain HK. Magnetic resonance colonography for the evaluation of colonic inflammatory bowel disease: correlation with conventional colonoscopy. J Comput Assist Tomogr. 2008; 32: 848-54.

A1a.50. Chen K, Fallen S, Abaan HO, Hayran M, Gonzalez C, Wodajo F, MacDonald T, Toretsky JA, Uren A. Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival. Pediatr Blood Cancer. 2008; 51: 349-55.

A1a.51. Saglam A, Hayran M, Uner AH. Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas. APMIS. 2008; 116: 791-800.

A1a.52. Alli N, Gur G, Yalcin B, Hayran M. Patient characteristics in Behcet disease: a retrospective analysis of 213 Turkish patients during 2001-4. Am J Clin Dermatol. 2009; 10: 411-8.

A1a.53. Deniz A, Yavuz B, Aytemir K, Hayran M, Kose S, Okutucu S, Tokgozoglu L, Kabakci G, Oto A. Intra-left atrial mechanical delay detected by tissue Doppler echocardiography can be a useful marker for paroxysmal atrial fibrillation. Echocardiography. 2009; 26: 779-84.

A1a.54. Ozsoy MH, Tuccar E, Demiryurek D, Bayramoglu A, Hayran M, Cavusoglu AT, Dincel VE, Sakaogullari A. Minimally invasive plating of the distal tibia: do we really sacrifice saphenous vein and nerve? A cadaver study. J Orthop Trauma. 2009; 23: 132-8.

A1a.55. Guler G, Huebner K, Himmetoglu C, Jimenez RE, Costinean S, Volinia S, Pilarski RT, Hayran M, Shapiro CL. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer. Cancer. 2009; 115: 899-908.

A1a.56. Aydin GB, Hayran M, Buyukpamukcu M. Undulant course of AFP: a sign of tumor activation or not? Pediatr Hematol Oncol. 2009; 26: 30-5.

A1a.57. Veras E, Mao TL, Ayhan A, Ueda S, Lai H, Hayran M, Shih Ie M, Kurman RJ. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol. 2009; 33: 844-53.

A1a.58. Ozsoy MH, Aydogdu S, Taskiran D, Sezak M, Hayran M, Oztop F, Ozsoy A. The effects of early or late treatment of osteochondral defects on joint homoeostasis: an experimental study in rabbits. Knee Surg Sports Traumatol Arthrosc. 2009; 17: 578-89.

A1a.59. Sade LE, Eroglu S, Bozbas H, Ozbicer S, Hayran M, Haberal A, Muderrisoglu H. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis. 2009; 204: 580-5.

A1a.60. Yemisci M, Sinici I, Ozkara HA, Hayran M, Ay H, Celtikci B, Onder E, Buyukserbetci G, Kaya EB, Tokgozoglu L, Dalkara T. Protective role of 27bp repeat polymorphism in intron 4 of eNOS gene in lacunar infarction. Free Radic Res. 2009; 43: 272-9.

A1a.61. Aksoy S, Dizdar O, Hayran M, Harputluoglu H. Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leuk Lymphoma. 2009; 50: 357-65.

A1a.62. Volkan-Salanci B, Dagdelen S, Alikasifoglu M, Erbas T, Hayran M, Erbas B. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus. J Renin Angiotensin Aldosterone Syst. 2009; 10: 41-50.

A1a.63. Kurt, M., Aksoy S, Hayran M, Güllü İ, Güler N. Retrospective analysis of capecitabie monotherapy in patients with Metastatic Breast Cancer: a single center experience. UHOD, 2009; 19: 9-17

A1a.64. Sinici I, Guven EO, Serefoglu E, Hayran M. T-786C polymorphism in promoter of eNOS gene as genetic risk factor in patients with erectile dysfunction in Turkish population. Urology. 2010; 75: 955-60.

A1a.65. Kupeli S, Hazirolan T, Varan A, Akata D, Alehan D, Hayran M, Besim A, Buyukpamukcu M. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol. 2010; 28: 1025-30.

A1a.66. Sinici I, Atalar E, Kepez A, Hayran M, Aksoyek S, Tokgozoglu L, Ozmen F. Intron 4 VNTR polymorphism of eNOS gene is protective for cardiac syndrome X. J Investig Med. 2010; 58: 23-7.

A1a.67. Kurt M, Onal IK, Parlak E, Shorbagi A, Kekilli M, Ibis M, Hayran M, Sasmaz N. Do metabolic alterations serve as biochemical markers in the diagnosis of malignant biliary obstruction? An observational study. Eur J Gastroenterol Hepatol. 2010; 22: 58-60.

A1a.68. Atahan L, Yildiz F, Cengiz M, Kaplan B, Ozkan M, Yazici G, Gundog M, Haydaroglu A, Korcum AF, Sengoz M, Dincer M, Akmansu M, Engin K, Hayran M. Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study. Support Care Cancer. 2010; 18: 691-8.

A1a.69. Kurt OK, Alpar S, Sipit T, Guven SF, Erturk H, Demirel MK, Korkmaz M, Hayran M, Kurt B. The diagnostic role of capnography in pulmonary embolism. Am J Emerg Med. 2010; 28: 460-5.

A1a.70. Kurt M, Akdogan M, Sayilir A, Kuran S, Ozderin YO, Arhan M, Onal IK, Kekilli M, Beyazit Y, Hayran M. Effect of endoscopic injection therapy with combined cyanoacrylate and lipiodol for bleeding gastric varices: A single center experience. J Dig Dis. 2010; 11: 284-90.

A1a.71. Hayran M, Abali H, Kilickap S, Mentes T, Aksoy H, Kemik A, Gokce H, Gokdemir H, Toplar S, Kaya D, Isbir GG. Socio-demographic parameters in screening for breast cancer: Lessons from a population-'based women's Health Project held in a province in Turkey. J BUON. 2010; 15: 726-31.

A1a.72. Yazici G, Yildiz F, Iskit A, Erdemli E, Surucu S, Firat P, Hayran M, Ozyigit G, Cengiz M. The effect of vitamin D prophylaxis on radiation induced pulmonary damage. J Radiat Res. 2011; 52: 616-21.

A1a.73. Kepez A, Niksarlioglu EY, Hazirolan T, Hayran M, Kocabas U, Demir AU, Aytemir K, Tokgozoglu L, Nazli N. Evaluation of association between obstructive sleep apnea and coronary risk scores predicted by tomographic coronary calcium scoring in asymptomatic patients. Anadolu Kardiyol Derg. 2011; 11: 428-35.

A1a.74. Karaman K, Bostanci EB, Aksoy E, Kurt M, Celep B, Ulas M, Dalgic T, Surmelioglu A, Hayran M, Akoglu M. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. Eur J Intern Med. 2011; 22: e95-8.

A1a.75. Oksuz C, Akel BS, Oskay D, Leblebicioglu G, Hayran KM. Cross-cultural adaptation, validation, and reliability process of the Michigan Hand Outcomes Questionnaire in a Turkish population. J Hand Surg Am. 2011; 36: 486-92.

A1a.76. Sari E, Guler G, Hayran M, Gullu I, Altundag K, Ozisik Y. Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer. Med Oncol. 2011; 28: 57-63.

A1a.77. Icli F, Akbulut H, Yalcin B, Ozdemir F, Isikdogan A, Hayran M, Unsal D, Coskun S, Buyukcelik A, Yamac D. Education, economic status and other risk factors in gastric cancer: "a case-control study of Turkish Oncology Group". Med Oncol. 2011; 28: 112-20.

A1a.78. Gultekin M, Ozyar E, Cengiz M, Ozyigit G, Hayran M, Hosal S, Akyol F. High daily fraction dose external radiotherapy for T1 glottic carcinoma: Treatment results and prognostic factors. Head Neck. 2011.

A1a.79. Senkal HA, Hayran M, Karakaya E, Yueh B, Weymuller EA, Jr., Hosal AS. The validity and reliability of the Turkish version of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer. Am J Otolaryngol. 2011.

A1a.80. Konan A, Hayran M, Kilic YA, Karakoc D, Kaynaroglu V. Scoring systems in the diagnosis of acute appendicitis in the elderly. Ulus Travma Acil Cerrahi Derg. 2011; 17: 396-400.

A1a.81. Akalın İ, Koca E, Karabulut HG, Haznedaroğlu İH, Çetiner D, Hayran M, Onal İK, Ozcebe OI, Tukun A. Angiotensin converting enzyme ınsertion/deletion gene polymorphism in leukemic hematopoiesis. UHOD, 2011; 21: 1-9

A1a.82. Arslan Ç, Kılıçkap S, Dede DS, Hayran KM, Erman M, Çelik İ, Kutluk T. 65 yaş ve üzeri popülasyonda kanser sıklığının dağılımı: Hacettepe Üniversitesi Hastaneleri Kanser Kayıt Sistemi Sonuçları. Turkish Journal of Geriatrics 2011; 14: 187-192

A1a.83. Gultekin M, Yildiz F, Ozyigit G, Beyaz H, Hayran M, Kose F, Yuce K, Ayhan A. Comparison of FIGO 1988 and 2009 staging systems for endometrial carcinoma. Med Oncol. 2012.

A1a.84. Akoglu G, Atakan N, Cakir B, Kalayci O, Hayran M. Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria. Arch Dermatol Res. 2012; 304: 257-62.

A1a.85. Ozgen A, Hayran, M, Kahraman F. Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapy. J Radiat Res. 2012; 53, 916-22.

A1a.86. Acilan C, Serhatli M, Kacar O, Adiguzel Z, Tuncer A, Hayran M, Baysal K. Smooth muscle cells isolated from thoracic aortic aneurysms exhibit increased genomic damage, but similar tendency for apoptosis. DNA Cell Biol. 2012, 31, 1523-34.

A1a.87. Kaya DO, Ergun N, Hayran M. Effects of different segmental spinal stabilization exercise protocols on postural stability in asymptomatic subjects: randomized controlled trial. J Back Musculoskelet Rehabil. 2012, 25, 109-16.

A1a.88. Aktas A, Er N, Onur MA, Tan G, Hayran M. Effects of ankaferd blood stopper on nerve conductanse: an experimental study on the rat sciatic nerve. UHOD 2012; 22: 9-14.

A1a.89 Erbil, K. M., D. Demiryurek, A. Bayramoglu, F. Kaymaz, M. Hayran, M. Tuncel and H. Erbil. "The Effect of Melatonin on Experimental Cold Injury of the Skin." Turkiye Klinikleri Tip Bilimleri Dergisi 28, no. 6 (2008): 828-833.

Lise	Ankara Atatürk Anadolu Lisesi 1988
Lisans	Hacettepe Üniversitesi Tıp Fakültesi 1994
Yüksek Öğrenim	Y.Lisans / Hacettepe Üniversitesi Kanser Epidemiyolojisi 1997 Doktora / University of Pittsburgh Halk Sağlığı (Epidemiyoloji) 2002
Yurtdışı Deneyim / Eğitim	Aynı zamanda Dünya Sağlık Örgütü Uluslararası Kanser Araştırmaları Ajansı (IARC), Amerika Birleşik Devletleri Ulusal Kanser Enstitüsü (NCI), Avrupa Kanser Araştırma ve Tedavisi Organizasyonu (EORTC), A.B.D.'de Michigan ve İtalya'da Pavia Üniversiteleri tarafından düzenlenmiş klinik araştırma yöntemleri, epidemiyoloji, biyoistatistik ve kanser kontrolü konulu kurslara katılmıştır.
Yabancı Dil	İngilizce

:

: mhayran@hacettepe.edu.tr